Health-related quality of life in KEYNOTE-010: a phase II/III study of Pembrolizumab versus Docetaxel in patients with previously treated advanced, programmed death ligand 1-Expressing NSCLC - Barlesi, Fabrice; Garon, Edward B; Kim, Dong-Wan; Felip, Enriqueta; Han, Ji-Youn; Kim, Joo-Hang; Ahn, Myung-Ju; Fidler, Mary Jo; Gubens, Matthew A.; Castro Junior, Gilberto de (Journal of thoracic oncology, 2019)